Tech Company Financing Transactions

Encore Vision Funding Round

Encore Vision closed a $2.5 million Series C funding round on 8/26/2015. Investors included private investors.

Transaction Overview

Company Name
Announced On
8/26/2015
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
4502 Starkey Road 109
Cave Spring, VA 24018
USA
Email Address
Not Recorded
Overview
Encore Vision, Inc. is an ophthalmic therapeutic company formed to develop treatments for presbyopia, directed at its primary cause.
Profile
Encore Vision LinkedIn Company Profile
Social Media
Encore Vision Company Twitter Account
Company News
Encore Vision News
Facebook
Encore Vision on Facebook
YouTube
Encore Vision on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
William Burns
  William Burns LinkedIn Profile  William Burns Twitter Account  William Burns News  William Burns on Facebook
Chief Scientific Officer
William Garner
  William Garner LinkedIn Profile  William Garner Twitter Account  William Garner News  William Garner on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/26/2015: RackWare venture capital transaction
Next: 8/27/2015: CrunchyRoll venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document tech company VC transactions. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary